Evaluation of an Intensive Education Program on the Treatment of Tobacco Use Disorder for Pharmacists: a Randomized Controlled Trial

NCT03518476 | Completed

• 1 other identifier: QatarU
• Study Type: interventional
• Target: 164
• Locations: 1 country
• Sites: 1

Brief Summary

In Qatar, tobacco use is one of the main causes of premature deaths and preventable diseases. As per the 2013 Global Adult Tobacco Survey (GATS), 12.1% of adults and 20.2% of men in Qatar smoke tobacco, and 55.4% of this smoke an average of 16 cigarettes or more per day. Moreover, 15.7% of school students aged 13 to 15 years currently use some form of tobacco according to the 2013 Global Youth Tobacco Survey (GYTS). In Qatar, tobacco-related diseases including cardiovascular diseases and cancers are highly prevalent. In an effort to reduce tobacco use, Qatar has ratified the WHO Framework Convention on Tobacco Control (FCTC) and has implemented many tobacco control initiatives. In spite of these measures, tobacco use is still rising in Qatar. Pharmacists practicing in retail/community pharmacy are often the first port of call for individuals requiring health advice in general. Evidence has proven that they have a pivotal role in health promotion and disease prevention including tobacco cessation. Hence, pharmacists have excellent opportunities to reduce tobacco use in Qatar. Yet, ambulatory and community pharmacists in Qatar are not sufficiently contributing to tobacco control. Based on published data, only 21% of community pharmacists in Qatar always or most of the time ask patients about their smoking status. Furthermore, when asked about their smoking cessation training, 89% of pharmacists did not receive any kind of education or training about smoking cessation counseling in the past. In an effort to build the capacity of pharmacists in Qatar, the aim of the proposed study is to design, implement and evaluate an intensive education program on tobacco treatment for pharmacists in Qatar. The study will be a prospective randomized controlled trial comparing the effectiveness of the education program on pharmacists' tobacco cessation-related knowledge, attitudes, self-efficacy, and skills.

Conditions

Smoking Cessation

Outcome Measures

Primary Outcomes (2)

• tobacco related knowledge post program

  This outcome will be assessed using a survey instrument

  at the end of the program (+ 1 DAY POST THE PROGRAM)

• tobacco cessation related skills difference between the 2 groups

  This outcome will be assessed using OSCE (Objective Structured Clinical Examination). Pharmacist's practical skills in the delivery of effective tobacco cessation will be assessed through the use of a performance-based assessment such as Objective Structured Clinical Examination (OSCE). Examples of skills to be assessed include communication skills in general, counselling skills, law and professional ethics, and interviewing skills. We propose a 5 to 8 station OSCE that will target core competencies and skills covered in the program. In the OSCE, each participant will be allocated 10 mins to interact with a standardized patient who will be trained using a validated script. Performance of participants will be assessed using validated assessment checklists.

  at the end of the program (+ 1 DAY AFTER THE PROGRAM)

Secondary Outcomes (3)

• tobacco cessation related skills difference between the 2 groups

  3-6 months post intervention

• tobacco related self-efficacy difference between the 2 groups

  at the end of the program (+ 1 DAY POST THE PROGRAM)

• tobacco related attitudes difference between the 2 groups

  at the end of the program (+ 1 DAY POST THE PROGRAM)

Study Arms (2)

Intervention arm

EXPERIMENTAL

Participants in the intervention group will participate in an intensive education program delivered by a multi-disciplinary group of educators, researchers, and clinicians with expertise in tobacco control and tobacco dependence treatment. The program will be delivered over 4 days (run over 2 weekends) with an average of eight contact hours per day (a total of 32 contact hours) at Qatar University.

Behavioral: intensive multi-disciplinary education program on tobacco treatment for pharmacists

Control arm

ACTIVE COMPARATOR

Non-tobacco related training or education sessions will delivered to pharmacists in the control group.

Other: Control arm

Interventions

intensive multi-disciplinary education program on tobacco treatment for pharmacists BEHAVIORAL

Participants in the intervention group will participate in an intensive education program delivered by a multi-disciplinary group of educators, researchers, and clinicians with expertise in tobacco control and tobacco dependence treatment. The program will be delivered over 4 days (run over 2 weekends) with an average of eight contact hours per day (a total of 32 contact hours) at Qatar University.

Intervention arm

Control arm OTHER

Participants in control arm will receive a non-tobacco related training or educational session

Control arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Retail/community pharmacists practicing in Qatar will be eligible for participation in the study.

You may not qualify if:

• None

Sponsors & Collaborators

• Qatar University: lead
• Hamad Medical Corporation: collaborator
• Weill Cornell Medical College in Qatar: collaborator
• International Islamic University Malaysia: collaborator
• University of Auckland, New Zealand: collaborator

Study Sites (1)

Qatar Univeristy

Doha, 2713, Qatar

Location

Related Publications (2)

• El Hajj MS, Awaisu A, Nik Mohamed MH, Saleh RA, Al Hamad NM, Kheir N, Mahfoud ZR. Assessment of an intensive education program for pharmacists on treatment of tobacco use disorder using an objective structured clinical examination: a randomized controlled trial. BMC Med Educ. 2022 Apr 18;22(1):289. doi: 10.1186/s12909-022-03331-9.

  PMID: 35436957 DERIVED

• El Hajj MS, Awaisu A, Kheir N, Mohamed MHN, Haddad RS, Saleh RA, Alhamad NM, Almulla AM, Mahfoud ZR. Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial. Trials. 2019 Jan 8;20(1):25. doi: 10.1186/s13063-018-3068-7.

  PMID: 30621772 DERIVED

MeSH Terms

Conditions

Smoking Cessation

Interventions

Pharmacists

Condition Hierarchy (Ancestors)

Health Behavior; Behavior

Intervention Hierarchy (Ancestors)

Health Personnel; Health Care Facilities Workforce and Services

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor and Chair of Clinical Pharmacy and Practice Section

Study Record Dates

• First Submitted: April 16, 2018
• First Posted: May 8, 2018
• Study Start: September 14, 2018
• Primary Completion: September 30, 2019
• Study Completion: September 30, 2019
• Last Updated: March 11, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

QA (1)